Titan Pharmaceuticals, Inc. (TTNP): Price and Financial Metrics

Titan Pharmaceuticals, Inc. (TTNP): $0.33

0.01 (-2.94%)

POWR Rating

Component Grades








Add TTNP to Watchlist
Sign Up

Industry: Biotech




#256 of 397

in industry

TTNP Price/Volume Stats

Current price $0.33 52-week high $1.09
Prev. close $0.34 52-week low $0.31
Day low $0.33 Volume 12,300
Day high $0.35 Avg. volume 43,874
50-day MA $0.41 Dividend yield N/A
200-day MA $0.62 Market Cap 4.97M

TTNP Stock Price Chart Interactive Chart >

TTNP Stock Summary

  • TITAN PHARMACEUTICALS INC's market capitalization of $5,135,573 is ahead of just 2.83% of US-listed equities.
  • With a year-over-year growth in debt of 176.39%, TITAN PHARMACEUTICALS INC's debt growth rate surpasses 94.8% of about US stocks.
  • As for revenue growth, note that TTNP's revenue has grown -46.5% over the past 12 months; that beats the revenue growth of merely 5.57% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to TITAN PHARMACEUTICALS INC, a group of peers worth examining would be TBIO, TARS, VLCN, CGNX, and OM.
  • Visit TTNP's SEC page to see the company's official filings. To visit the company's web site, go to www.titanpharm.com.

TTNP Valuation Summary

  • TTNP's price/earnings ratio is -0.9; this is 103.39% lower than that of the median Healthcare stock.
  • Over the past 243 months, TTNP's price/sales ratio has gone down 287.7.

Below are key valuation metrics over time for TTNP.

Stock Date P/S P/B P/E EV/EBIT
TTNP 2023-11-20 17.6 0.7 -0.9 0.3
TTNP 2023-11-17 16.7 0.6 -0.8 0.4
TTNP 2023-11-16 18.3 0.7 -0.9 0.3
TTNP 2023-11-15 18.3 0.7 -0.9 0.3
TTNP 2023-11-14 19.6 0.7 -1.0 0.2
TTNP 2023-11-13 14.9 -5.7 -0.7 -0.7

TTNP Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at 29.83%.
  • The 5 year net cashflow from operations growth rate now stands at -413.14%.
  • Its 2 year revenue growth rate is now at -74.11%.
TTNP's revenue has moved down $3,039,000 over the prior 33 months.

The table below shows TTNP's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.572 -7.685 -10.18
2022-06-30 0.741 -8.074 -9.457
2022-03-31 1.036 -8.238 -8.675
2021-12-31 1.526 -7.899 -8.776
2021-09-30 2.448 -11.379 -9.321
2021-06-30 3.304 -12.564 -12.338

TTNP Price Target

For more insight on analysts targets of TTNP, see our TTNP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $7.00 Average Broker Recommendation 1.5 (Moderate Buy)

Titan Pharmaceuticals, Inc. (TTNP) Company Bio

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company was founded in 1992 and is based in South San Francisco, California.

TTNP Latest News Stream

Event/Time News Detail
Loading, please wait...

TTNP Latest Social Stream

Loading social stream, please wait...

View Full TTNP Social Stream

Latest TTNP News From Around the Web

Below are the latest news stories about TITAN PHARMACEUTICALS INC that investors may wish to consider to help them evaluate TTNP as an investment opportunity.

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") is pleased to announce the appointments of Dato’ Seow Gim Shen and Brynner Chiam to the Company’s Board of Directors, effective October 12, 2023. Mr. Shen has also been appointed Chairman of the Board. Simultaneous with the election of Mr. Shen and Mr. Chiam to the Board, David E. Lazar and Peter L. Chasey each submitted their resignations from the Board, effective immediately.

Yahoo | October 16, 2023

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

SAN FRANCISCO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that it has entered into a definitive securities purchase agreement (the “Purchase Agreement”) with The Sire Group Ltd. (“Sire Group”) for the sale of the Company’s newly designated Series AA Convertible Preferred Stock (the “Preferred Stock”). Sire Group purchased 950,000 shares of Preferred Stock for an aggregate purchase price of $9,500,000, consisting of (i)

Yahoo | September 18, 2023

Unveiling Titan Pharmaceuticals (TTNP)'s Value: Is It Really Priced Right? A Comprehensive Guide

Investigating the valuation of Titan Pharmaceuticals Inc (TTNP) and its potential for future returns

Yahoo | August 28, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!

William White on InvestorPlace | July 28, 2023

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

Company to receive $2 million in upfront payments, with the potential to receive up to $50 million in milestone payments and single digit royalty payments on future net salesSAN FRANCISCO, July 27, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into an Asset Purchase Agreement (the “Agreement”) with Fedson, Inc., a Delaware Corporation (“Fedson”), for the sale of certain ProNeura assets including Titan’s portfoli

Yahoo | July 27, 2023

Read More 'TTNP' Stories Here

TTNP Price Returns

1-mo -23.26%
3-mo -35.80%
6-mo -56.58%
1-year -65.80%
3-year -90.57%
5-year -99.36%
YTD -57.86%
2022 -23.23%
2021 -69.00%
2020 -43.50%
2019 -85.30%
2018 -83.40%

Continue Researching TTNP

Here are a few links from around the web to help you further your research on Titan Pharmaceuticals Inc's stock as an investment opportunity:

Titan Pharmaceuticals Inc (TTNP) Stock Price | Nasdaq
Titan Pharmaceuticals Inc (TTNP) Stock Quote, History and News - Yahoo Finance
Titan Pharmaceuticals Inc (TTNP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!